Common Stock, Shares, Outstanding of ENDRA Life Sciences Inc. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
ENDRA Life Sciences Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • ENDRA Life Sciences Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 786,902, a 47% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

ENDRA Life Sciences Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 786,902 +252,039 +47% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 752,390 -71,687,136 -99% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 562,213 -10,352,234 -95% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 536,908 +530,971 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 534,863 -7,876,914 -94% 30 Sep 2024 10-Q/A 21 Nov 2024 2024 Q3
Q2 2024 72,439,526 +64,957,923 +868% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 10,914,447 +7,745,344 +244% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 5,937* -3,163,166 31 Dec 2023 10-K/A 07 Apr 2025 2024 FY
Q3 2023 8,411,777 -54,762,678 -87% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 7,481,603 -55,692,852 -88% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 3,169,103 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 3,169,103 +1,041,378 +49% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 63,174,455 +21,008,729 +50% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 63,174,455 +21,317,103 +51% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q4 2021 2,127,725 -31,921,979 -94% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 42,165,726 +17,150,016 +69% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 41,857,352 +25,419,861 +155% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 41,614,653 +28,061,648 +207% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 34,049,704 +25,628,303 +304% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 25,015,710 +17,498,835 +233% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 16,437,491 +9,014,849 +121% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 13,553,005 +6,130,363 +83% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 8,421,401 +998,759 +13% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 7,516,875 +3,569,047 +90% 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 7,422,642 +3,499,615 +89% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 7,422,642 +3,499,615 +89% 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 7,422,642 +3,499,615 +89% 31 Dec 2018 10-K 26 Mar 2020 2019 FY
Q3 2018 3,947,828 +40,801 +1% 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 3,923,027 +16,000 +0.41% 30 Jun 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 3,923,027 +3,199,692 +442% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 3,923,027 +3,199,692 +442% 31 Dec 2017 10-K 11 Mar 2019 2018 FY
Q3 2017 3,907,027 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 3,907,027 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 723,335 31 Mar 2017 10-Q 21 Jun 2017 2017 Q1
Q4 2016 723,335 31 Dec 2016 10-K 20 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.